The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

Despite new treatment modalities, the clinical outcome in a substantial number of patients with multiple myeloma (MM) has yet to be improved. Antibody-based targeted therapies for myeloma patients could make use of the HM1.24 antigen (CD317), a surface molecule overexpressed on malignant plasma cell...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Staudinger, M, Glorius, P, Burger, R, Kellner, C, Klausz, K, Günther, A, Repp, R, Klapper, W, Gramatzki, M, Peipp, M
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2014
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080209/
https://ncbi.nlm.nih.gov/pubmed/24927408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2014.38
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky